PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 13 results · Off-label Promotion · Diabetes  · Clear
🔒 Subscribers only
AUTH/3788/6/23
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca
A health professional complained about the “SPONSORED” section of a third-party publisher’s email newsletter. The sponsored content block read: “Sponsored: See Beyond Sugar: Using NICE NG28…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3779/6/23
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AUTH/3779/6/23 & AUTH/3780/6/23
An anonymous, non-contactable complainant (described as a former employee) raised concerns about the promotional material approval process (PMAP) used within the Boehringer Ingelheim (BI) and Eli L…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3481/3/21
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant (described as a Sanofi employee) raised concerns about internal communications relating to Suliqua (insulin glargine with lixisenatide).An internal email c…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3486/3/21
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant (self-described health professional) complained about alleged off-licence promotion of Suliqua (insulin glargine + lixisenatide) by Sanofi.The complainant …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3491/3/21
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant (self-described health professional) alleged off-licence promotion of Suliqua (insulin glargine/lixisenatide) by Sanofi.The complainant said a diabetes nur…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3062/8/18
Off-label Promotion Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi Toujeo leavepiece
A consultant physician complained about a six-page A5 gate-folded promotional leavepiece for Toujeo (insulin glargine 300 units/mL) (SAGB.TJO.18.06.0924(1)).The leavepiece discussed the BRIGHT head…
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/2825/3/16
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Janssen v Boehringer Ingelheim & Lilly
Janssen-Cilag complained about a two-sided A4 “Dear UK Healthcare Professional” letter (ref UK/EMP/00241) about Jardiance (empagliflozin) cardiovascular outcomes.The letter was stapled to a rep…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2835/4/16
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Janssen voluntary admission over outdated Invokana prescribing information email (No breach)
Janssen-Cilag’s mailing agency inadvertently sent general practitioners a previously withdrawn promotional email for Invokana (canagliflozin) (ref PHGB/VOK/1015/0078) containing outdated prescrib…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2125/5/08
Off-label Promotion Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Takeda Europe Actos (pioglitazone) journal advertisement
GlaxoSmithKline UK Ltd complained about an advertisement (ref ACT179) for Actos (pioglitazone) placed by Takeda Pharmaceuticals Europe Limited in Diabetologia, April 2008 (and reprinted in the May …
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/1997/5/07
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Takeda
GlaxoSmithKline (GSK) complained about a four-page Takeda mailing to GPs (ref AC070230) promoting a new indication for Actos (pioglitazone): use in combination with insulin in certain type 2 diabet…
Clauses: NONE
2007 🔒 Subscribe
🔒 Subscribers only
AUTH/1802/2/06
Off-label Promotion Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Merck breached ABPI Code over ‘More GI-friendly’ Glucophage SR ad and illegible prescribing informat
A head of medicines management at a primary care trust complained about a Merck journal advertisement for Glucophage SR (prolonged release metformin) in Prescriber (19 February; ad ref December 200…
Clauses: 4.1,9.1
2006 🔒 Subscribe
🔒 Subscribers only
AUTH/1922/11/06
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
GSK
GlaxoSmithKline (GSK) voluntarily informed the PMCPA that out of date prescribing information (PI) had been used in Avandamet (rosiglitazone/metformin) advertisements.The outdated PI (dated April 2…
Clauses: NONE
2006 🔒 Subscribe
🔒 Subscribers only
AUTH/1796/2/06
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Novo Nordisk animal insulin discontinuation leaflet
A Primary Care Trust head of prescribing complained about a four-page Novo Nordisk leaflet titled Discontinuation Announcement (ref INS/525/1205), prepared January 2006.Page 1 was a “Dear Colleag…
Clauses: NONE
2006 🔒 Subscribe
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews